Heliox administration in patients with COPD exacerbation – Technical aspects

R. Zazula, K. Roubík, T. Tyll, M. Müller, V. Zábrodský, J. Chlumský, A. Strnadová, A. Spálený (Prague, Czech Republic)

Source: Annual Congress 2010 - Mechanical ventilation and weaning
Session: Mechanical ventilation and weaning
Session type: E-Communication Session
Number: 2233
Disease area: Airway diseases, Respiratory critical care

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Zazula, K. Roubík, T. Tyll, M. Müller, V. Zábrodský, J. Chlumský, A. Strnadová, A. Spálený (Prague, Czech Republic). Heliox administration in patients with COPD exacerbation – Technical aspects. Eur Respir J 2010; 36: Suppl. 54, 2233

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Symptoms experienced by COPD patients during exacerbations and their association with healthcare utilization – EXACO study
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011

Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Predictors of PAO2 and PaCO2 in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Respiratory muscle function during and after a severe exacerbation of COPD – Preliminary results
Source: Annual Congress 2011 - Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles
Year: 2011


Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014


Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014

Characteristics of patients with chronic obstructive pulmonary disease (COPD) discharged from the emergency department – Improving the care pathway for acute exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011


Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD)
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


Intractable breathlessness in COPD – A suitable case for palliation
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010


The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Intractable breathlessness in COPD – A suitable case for palliation?
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011


Diagnosing COPD and asthma in primary care in Israel – The challenge and the change
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011


Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Living with chronic obstructive pulmonary disease (COPD) – A lifeworld perspective
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010


Impact of mucolytic treatment on COPD exacerbations
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013